(c) 2024 PillSync.com

Temazepam 30 MG Oral Capsule

INDICATIONS AND USAGE Temazepam capsules are indicated for the short-term treatment of insomnia (generally 7 to 10 days). For patients with short-term insomnia, instructions in the prescription should indicate that temazepam capsules should be used for short periods of time (7 to 10 days). The clinical trials performed in support of efficacy were 2 weeks in duration with the final formal assessment of sleep latency performed at the end of treatment.

Actavis Pharma, Inc.


3 years ago CAPSULE WHITE R 077 Temazepam 30 MG Oral Capsule

CAPSULE WHITE R 077

3 years ago CAPSULE WHITE R 077 Temazepam 30 MG Oral Capsule

R 077 CAPSULE WHITE

HOW SUPPLIED

TEMAZEPAM capsules, USP are available as follows: 15 mg — Each #3 capsule with green opaque cap and white opaque body, imprinted with 076 in black ink on both cap and body contains 15 mg of

TEMAZEPAM, USP. capsules are supplied in bottles of 100 (NDC 0228-2076-10) and 500 (NDC 0228-2076-50). 30 mg — Each #3 capsule with white opaque cap and body, imprinted with 077 in black ink on both cap and body contains 30 mg of

TEMAZEPAM, USP. capsules are supplied in bottles of 100 (NDC 0228-2077-10) and 500 (NDC 0228-2077-50). Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F). Dispense with Medication Guide available at: www.tevausa.com/medguides Manufactured For: Teva Pharmaceuticals Parsippany, NJ 07054 Rev. D 2/2023 1 1


More pills like CAPSULE R 077

Related Pills

Temazepam 30 MG Oral Capsule

Actavis Pharma, Inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site